Page last updated: 2024-12-10

6-mercapto-7-methylguanosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

6-mercapto-7-methylguanosine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5494430
CHEMBL ID1234483
MeSH IDM0201603

Synonyms (17)

Synonym
CHEMBL1234483
2-amino-9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-methylpurin-9-ium-6-thiolate
6-mercapto-7-methylguanosine
2-amino-6-mercapto-7-methylpurine ribonucleoside
5f1954x1mn ,
1h-purinium, 2-amino-6,9-dihydro-7-methyl-9-beta-d-ribofuranosyl-6-thioxo-, hydroxide, inner salt
2-amino-6,9-dihydro-7-methyl-9-beta-d-ribofuranosyl-6-thioxo-1h-purinium hydroxide, inner salt
unii-5f1954x1mn
6-thio-7-methylguanosine
1h-purinium, 2-amino-6,9-dihydro-7-methyl-9-.beta.-d-ribofuranosyl-6-thioxo-, inner salt
guanosine, 7-methyl-6-thio-
2-amino-7-methyl-9-beta-d-ribofuranosyl-9h-purin-7-ium-6-thiolate
7-methyl-6-thioguanosine (technical grade)
Q27261945
PD018378
DTXSID601235975
AKOS040744092
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Eukaryotic translation initiation factor 4EHomo sapiens (human)IC50 (µMol)400.00003.00003.00003.0000AID241783
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
negative regulation of autophagyEukaryotic translation initiation factor 4EHomo sapiens (human)
G1/S transition of mitotic cell cycleEukaryotic translation initiation factor 4EHomo sapiens (human)
behavioral fear responseEukaryotic translation initiation factor 4EHomo sapiens (human)
mRNA export from nucleusEukaryotic translation initiation factor 4EHomo sapiens (human)
translational initiationEukaryotic translation initiation factor 4EHomo sapiens (human)
regulation of translationEukaryotic translation initiation factor 4EHomo sapiens (human)
negative regulation of translationEukaryotic translation initiation factor 4EHomo sapiens (human)
stem cell population maintenanceEukaryotic translation initiation factor 4EHomo sapiens (human)
neuron differentiationEukaryotic translation initiation factor 4EHomo sapiens (human)
negative regulation of neuron differentiationEukaryotic translation initiation factor 4EHomo sapiens (human)
positive regulation of mitotic cell cycleEukaryotic translation initiation factor 4EHomo sapiens (human)
cellular response to dexamethasone stimulusEukaryotic translation initiation factor 4EHomo sapiens (human)
regulation of translation at postsynapse, modulating synaptic transmissionEukaryotic translation initiation factor 4EHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (9)

Processvia Protein(s)Taxonomy
RNA cap bindingEukaryotic translation initiation factor 4EHomo sapiens (human)
RNA 7-methylguanosine cap bindingEukaryotic translation initiation factor 4EHomo sapiens (human)
RNA bindingEukaryotic translation initiation factor 4EHomo sapiens (human)
translation initiation factor activityEukaryotic translation initiation factor 4EHomo sapiens (human)
protein bindingEukaryotic translation initiation factor 4EHomo sapiens (human)
enzyme bindingEukaryotic translation initiation factor 4EHomo sapiens (human)
eukaryotic initiation factor 4G bindingEukaryotic translation initiation factor 4EHomo sapiens (human)
mRNA cap bindingEukaryotic translation initiation factor 4EHomo sapiens (human)
DNA-binding transcription factor bindingEukaryotic translation initiation factor 4EHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (14)

Processvia Protein(s)Taxonomy
P-bodyEukaryotic translation initiation factor 4EHomo sapiens (human)
nucleusEukaryotic translation initiation factor 4EHomo sapiens (human)
cytoplasmEukaryotic translation initiation factor 4EHomo sapiens (human)
cytosolEukaryotic translation initiation factor 4EHomo sapiens (human)
cytoplasmic stress granuleEukaryotic translation initiation factor 4EHomo sapiens (human)
eukaryotic translation initiation factor 4F complexEukaryotic translation initiation factor 4EHomo sapiens (human)
nuclear speckEukaryotic translation initiation factor 4EHomo sapiens (human)
chromatoid bodyEukaryotic translation initiation factor 4EHomo sapiens (human)
cytoplasmic ribonucleoprotein granuleEukaryotic translation initiation factor 4EHomo sapiens (human)
perinuclear region of cytoplasmEukaryotic translation initiation factor 4EHomo sapiens (human)
extracellular exosomeEukaryotic translation initiation factor 4EHomo sapiens (human)
postsynapseEukaryotic translation initiation factor 4EHomo sapiens (human)
glutamatergic synapseEukaryotic translation initiation factor 4EHomo sapiens (human)
RISC complexEukaryotic translation initiation factor 4EHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID241783Inhibitory concentration against 7-methyl-GTP binding to eukaryotic translation initiation factor 4E2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Synthesis and evaluation of potential inhibitors of eIF4E cap binding to 7-methyl GTP.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (50.00)18.2507
2000's2 (20.00)29.6817
2010's2 (20.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]